TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI

Volume: 8 Number: 4 October 1, 2005
  • Taner Turan
  • Serap Bozok
  • Nurettin Boran
  • Nejat Özgül
  • Reyhan Öcalan
  • Gökhan Tulunay
  • M. Faruk Köse
EN TR

Abstract

Objective: The aim of this study was to evaluate the prognostic significance of pretreatment thrombocytosis in epithelial ovarian cancer.Material and methods: Between 1993 and 2006, 391 patients with epithelial ovarian cancer, which were treated, are evaluated retrospectively. The platelet count >400.000/mm3 accepted as a thrombocytosis. To analyze statistically used Anova Table Test and Chi-Square test.Results: The mean age of the patients was 59.7 years (27-90) and the mean of the pretreatment platelet count was 364.000/mm3 (59.000-991.000). 32% of patients had pretreatment thrombocytosis. The stage, pretreatment CA 125 levels, presence of ascites and volume of ascites were affected by pretreatment thrombocytosis. While the recurrence rate was high in patients with thrombocytosis, disease free survival time, overall survival time and survival rate was not found to be related with thrombocytosis.Conclusion: Thrombocytosis can be marker of tumor aggresivity. The malignancy must be kept in mind for patient with pelvic mass and thrombocytosis.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Taner Turan This is me

Serap Bozok This is me

Nurettin Boran This is me

Nejat Özgül This is me

Reyhan Öcalan This is me

Gökhan Tulunay This is me

M. Faruk Köse This is me

Publication Date

October 1, 2005

Submission Date

October 1, 2005

Acceptance Date

-

Published in Issue

Year 2005 Volume: 8 Number: 4

APA
Turan, T., Bozok, S., Boran, N., Özgül, N., Öcalan, R., Tulunay, G., & Köse, M. F. (2005). TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI. Türk Jinekolojik Onkoloji Dergisi, 8(4), 117-121. https://izlik.org/JA92WW77AX
AMA
1.Turan T, Bozok S, Boran N, et al. TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI. Türk Jinekolojik Onkoloji Dergisi. 2005;8(4):117-121. https://izlik.org/JA92WW77AX
Chicago
Turan, Taner, Serap Bozok, Nurettin Boran, et al. 2005. “TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI”. Türk Jinekolojik Onkoloji Dergisi 8 (4): 117-21. https://izlik.org/JA92WW77AX.
EndNote
Turan T, Bozok S, Boran N, Özgül N, Öcalan R, Tulunay G, Köse MF (October 1, 2005) TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI. Türk Jinekolojik Onkoloji Dergisi 8 4 117–121.
IEEE
[1]T. Turan et al., “TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI”, Türk Jinekolojik Onkoloji Dergisi, vol. 8, no. 4, pp. 117–121, Oct. 2005, [Online]. Available: https://izlik.org/JA92WW77AX
ISNAD
Turan, Taner - Bozok, Serap - Boran, Nurettin - Özgül, Nejat - Öcalan, Reyhan - Tulunay, Gökhan - Köse, M. Faruk. “TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI”. Türk Jinekolojik Onkoloji Dergisi 8/4 (October 1, 2005): 117-121. https://izlik.org/JA92WW77AX.
JAMA
1.Turan T, Bozok S, Boran N, Özgül N, Öcalan R, Tulunay G, Köse MF. TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI. Türk Jinekolojik Onkoloji Dergisi. 2005;8:117–121.
MLA
Turan, Taner, et al. “TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI”. Türk Jinekolojik Onkoloji Dergisi, vol. 8, no. 4, Oct. 2005, pp. 117-21, https://izlik.org/JA92WW77AX.
Vancouver
1.Taner Turan, Serap Bozok, Nurettin Boran, Nejat Özgül, Reyhan Öcalan, Gökhan Tulunay, M. Faruk Köse. TEDAVİ ÖNCESİ TROMBOSİTOZUN EPİTELİYAL OVER KANSERLİ HASTALARDA PROGNOSTİK ANLAMI. Türk Jinekolojik Onkoloji Dergisi [Internet]. 2005 Oct. 1;8(4):117-21. Available from: https://izlik.org/JA92WW77AX